Agenda
8:00 AM | Registration and Breakfast (TRC Lobby) |
8:30 AM
|
Welcome and Introduction
J. Larry Jameson, MD, PhD |
8:40 AM |
Research at the Intersection of Metabolic and Cardiovascular Disease at Penn
Daniel J. Rader, MD
|
Session 1 - Session Chair: Mitchell A. Lazar, MD, PhD |
|
9:00 AM |
"Epigenomic Modulation of Diabetes and Exercise Tolerance"
Mitchell A. Lazar, MD, PhD |
9:25 AM |
“Control of Hepatic Triglyceride Synthesis and Secretion”
Morris J. Birnbaum, MD, PhD |
9:50 AM |
“Mechanisms of the Cardio-Protective Effects of GLP-1”
Richard P. Shannon, MD |
10:15 AM | Coffee Break |
Session 2 - Session Chair: Michael S. Parmacek, MD |
|
10:30 AM |
"Penn CVI and IDOM: Targeting Cardiovascular-Metabolic Diseases"
Michael S. Parmacek, MD |
10:55 AM |
"Human Genetics of Heart Disease in the context of Diabetes: questions, approaches, and data"
Benjamin F. Voight, MD, PhD |
11:15 AM |
“Translational models in cardiometabolic disease”
Muredach P. Reilly, MBBCh, MSCE Associate Professor of Medicine, Cardiovascular Division |
11:40 AM |
“Regulation of mtDNA abundance and packaging as a determinant for cardiovascular” outcomes
Brett A. Kaufman, PhD
|
Keynote Address |
|
12:00 Noon |
“Deciphering the Metabolic Origins of Heart Failure: A Systems Approach”
Daniel P. Kelly, MD Scientific Director, Sanford-Burnham Medical Research Institute-Lake Nona |
12:55 PM | Concluding Remarks - Daniel J. Rader, MD |
1:00 PM | Lunch |